Department of Molecular Medicine and Anatomy, Nippon Medical School, Tokyo, Japan.
PLoS One. 2013 Jul 26;8(7):e69496. doi: 10.1371/journal.pone.0069496. Print 2013.
MicroRNA miR-376c was expressed in normal intrahepatic biliary epithelial cells (HIBEpiC), but was significantly suppressed in the HuCCT1 intrahepatic cholangiocarcinoma (ICC) cell line. The biological significance of the down-regulation of miR-376c in HuCCT1 cells is unknown. We hypothesized that miR-376c could function as a tumor suppressor in these cells. To test this hypothesis, we sought the targets of miR-376c, and characterized the effect of its down-regulation on HuCCT1 cells. We performed proteomic analysis of miR-376c-overexpressing HuCCT1 cells to identify candidate targets of miR-376c, and validated these targets by 3'-UTR reporter assay. Transwell migration assays were performed to study the migratory response of HuCCT1 cells to miR-376c overexpression. Furthermore, microarrays were used to identify the signaling that were potentially involved in the miR-376c-modulated migration of HuCCT1. Finally, we assessed epigenetic changes within the potential promoter region of the miR-376c gene in these cells. Proteomic analysis and subsequent validation assays showed that growth factor receptor-bound protein 2 (GRB2) was a direct target of miR-376c. The transwell migration assay revealed that miR-376c significantly reduced epidermal growth factor (EGF)-dependent cell migration in HuCCT1 cells. DNA microarray and subsequent pathway analysis showed that interleukin 1 beta and matrix metallopeptidase 9 were possible participants in EGF-dependent migration of HuCCT1 cells. Bisulfite sequencing showed higher methylation levels of CpG sites upstream of the miR-376c gene in HuCCT1 relative to HIBEpiC cells. Combined treatment with the DNA-demethylating agent 5-aza-2'-deoxycytidine and the histone deacetylase inhibitor trichostatin A significantly upregulated the expression of miR-376c in HuCCT1 cells. We revealed that epigenetic repression of miR-376c accelerated EGF-dependent cell migration through its target GRB2 in HuCCT1 cells. These findings suggest that miR-376c functions as a tumor suppressor. Since metastasis is the major cause of death in ICC, microRNA manipulation could lead to the development of novel anti-cancer therapy strategies for ICC.
微小 RNA miR-376c 在正常的肝内胆管上皮细胞 (HIBEpiC) 中表达,但在 HuCCT1 肝内胆管癌 (ICC) 细胞系中显著受到抑制。miR-376c 在 HuCCT1 细胞中的下调的生物学意义尚不清楚。我们假设 miR-376c 可以在这些细胞中作为肿瘤抑制因子发挥作用。为了验证这一假设,我们寻找了 miR-376c 的靶标,并描述了其下调对 HuCCT1 细胞的影响。我们对 miR-376c 过表达的 HuCCT1 细胞进行了蛋白质组学分析,以鉴定 miR-376c 的候选靶标,并通过 3'-UTR 报告基因检测进行了验证。Transwell 迁移实验用于研究 HuCCT1 细胞对 miR-376c 过表达的迁移反应。此外,还使用微阵列鉴定了可能参与 miR-376c 调节的 HuCCT1 迁移的信号通路。最后,我们评估了这些细胞中 miR-376c 基因潜在启动子区域内的表观遗传变化。蛋白质组学分析和随后的验证实验表明,生长因子受体结合蛋白 2 (GRB2) 是 miR-376c 的直接靶标。Transwell 迁移实验表明,miR-376c 显著降低了 HuCCT1 细胞中表皮生长因子 (EGF) 依赖性细胞迁移。DNA 微阵列和随后的通路分析表明,白细胞介素 1β和基质金属蛋白酶 9 可能参与 HuCCT1 细胞中 EGF 依赖性迁移。亚硫酸氢盐测序显示 HuCCT1 中 miR-376c 基因上游 CpG 位点的甲基化水平高于 HIBEpiC 细胞。联合使用 DNA 去甲基化剂 5-氮杂-2'-脱氧胞苷和组蛋白去乙酰化酶抑制剂曲古抑菌素 A 可显著上调 HuCCT1 细胞中 miR-376c 的表达。我们揭示了 miR-376c 通过其靶标 GRB2 在 HuCCT1 细胞中对 EGF 依赖性细胞迁移的表观遗传抑制作用。这些发现表明,miR-376c 作为肿瘤抑制因子发挥作用。由于转移是 ICC 患者死亡的主要原因,因此 miRNA 调控可能为 ICC 的新型抗癌治疗策略的发展提供依据。